DCF — ALTA BATES MEDICAL CENTER
Enterprise Value: $-1.9B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.9B
Enterprise Value
$-572.5M
PV of Cash Flows
$-1.3B
PV of Terminal Value
$-2.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $646.6M | $-125.7M | -19.0% | $-153.1M | $-139.2M |
| Year 2 | $666.0M | $-122.8M | -18.0% | $-151.0M | $-124.8M |
| Year 3 | $686.0M | $-119.7M | -17.0% | $-148.7M | $-111.7M |
| Year 4 | $706.6M | $-119.7M | -17.0% | $-149.6M | $-102.2M |
| Year 5 | $727.8M | $-121.5M | -17.0% | $-152.3M | $-94.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.9B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$627.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1994405560882193
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5